Jefferies Upgrades Pediatrix Medical Group to Buy, Raises Price Target to $14
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Jack Slevin has upgraded Pediatrix Medical Group (NYSE:MD) from Hold to Buy, raising the price target from $8 to $14.
September 26, 2024 | 3:32 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jefferies has upgraded Pediatrix Medical Group from Hold to Buy, with a new price target of $14, indicating a positive outlook for the stock.
The upgrade from Hold to Buy by Jefferies, along with a significant increase in the price target from $8 to $14, suggests a strong positive sentiment from the analyst. This is likely to boost investor confidence and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100